Atlas Venture Life Science Advisors, LLC Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$830.2B
Holdings
17
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DAWNDay One Biopharmaceuticals, Inc. | 7,568,317 | $162.9B | 19.62% | |
| 2 | KYMRKymera Therapeutics, Inc. | 5,984,736 | $149.4B | 17.99% | |
| 3 | DYNDyne Therapeutics, Inc. | 9,869,483 | $114.4B | 13.78% | |
| 4 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $73.0B | 8.79% | |
| 5 | IRONDisc Medicine, Inc. | 3,461,784 | $68.9B | 8.29% | |
| 6 | AVTEAerovate Therapeutics, Inc. | 2,017,521 | $59.1B | 7.12% | |
| 7 | REPLReplimune Group, Inc. | 2,098,300 | $57.1B | 6.87% | |
| 8 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $46.9B | 5.65% | |
| 9 | AKROAkero Therapeutics, Inc. | 594,251 | $32.6B | 3.92% | |
| 10 | GBIOGBXGeneration Bio, Co. | 8,278,876 | $32.5B | 3.92% | |
| 11 | —Ikena Oncology, Inc. | 5,018,178 | $13.3B | 1.61% | |
| 12 | XLOXilio Therapeutics, Inc. | 2,759,344 | $7.4B | 0.89% | |
| 13 | —F-star Therapeutics, Inc. | 599,524 | $3.8B | 0.46% | |
| 14 | —AVROBIO INC | 4,520,863 | $3.2B | 0.39% | |
| 15 | VRDNViridian Therapeutics, Inc. | 90,072 | $2.6B | 0.32% | |
| 16 | SPROSPERO THERAPEUTICS INC | 1,031,160 | $1.8B | 0.21% | |
| 17 | —MAGENTA THERAPEUTICS INC | 3,476,536 | $1.4B | 0.17% |